Donald William Kufe
Direktor/Vorstandsmitglied bei Linus Pharmaceuticals, Inc.
Profil
Donald William Kufe is currently a Director at Linus Pharmaceuticals, Inc., a Professor at Dana-Farber Cancer Institute, Inc., and a Professor at Harvard Medical School.
He was formerly a Director at Fennec Pharmaceuticals, Inc. from 2003 to 2009, an Independent Director at Synta Pharmaceuticals Corp.
from 2011 to 2016, and a Director at Bradmer Pharmaceuticals, Inc. from 2008 to 2010.
He also served as a Director at Genus Oncology LLC.
Kufe received his undergraduate degree from Bowdoin College and his doctorate from the University of Rochester Medical Center.
Aktive Positionen von Donald William Kufe
| Unternehmen | Position | Beginn |
|---|---|---|
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.1979 |
| Linus Pharmaceuticals, Inc. | Direktor/Vorstandsmitglied | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Donald William Kufe
| Unternehmen | Position | Ende |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Direktor/Vorstandsmitglied | 22.07.2016 |
Bradmer Pharmaceuticals, Inc.
 Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 26.03.2010 |
| FENNEC PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 07.07.2009 |
Genus Oncology LLC
 Genus Oncology LLC BiotechnologyHealth Technology Genus Oncology LLC operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the treatment of patients with refractory cancers. The company was founded in 2007 and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | - |
Ausbildung von Donald William Kufe
| Bowdoin College | Undergraduate Degree |
| University of Rochester Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Bradmer Pharmaceuticals, Inc.
Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Genus Oncology LLC
Genus Oncology LLC BiotechnologyHealth Technology Genus Oncology LLC operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the treatment of patients with refractory cancers. The company was founded in 2007 and is headquartered in Chicago, IL. | Health Technology |
| Linus Pharmaceuticals, Inc. |
